ARCHIVES

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998

Oklahoma Cancer Center Recruits Four Professors.

June 15, 2001

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012

Caribbean Conference Reports Incidence Differences With U.S.

August 22, 1986